Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement.

Contois JH, Warnick GR, Sniderman AD.

J Clin Lipidol. 2011 Jul-Aug;5(4):264-72. doi: 10.1016/j.jacl.2011.05.004. Epub 2011 May 27. Review.

PMID:
21784371
2.

A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk.

Sniderman AD, Williams K, Contois JH, Monroe HM, McQueen MJ, de Graaf J, Furberg CD.

Circ Cardiovasc Qual Outcomes. 2011 May;4(3):337-45. doi: 10.1161/CIRCOUTCOMES.110.959247. Epub 2011 Apr 12.

3.

Comparisons of apolipoprotein B levels estimated by immunoassay, nuclear magnetic resonance, vertical auto profile, and non-high-density lipoprotein cholesterol in subjects with hypertriglyceridemia (SAFARI Trial).

Grundy SM, Vega GL, Tomassini JE, Tershakovec AM.

Am J Cardiol. 2011 Jul 1;108(1):40-6. doi: 10.1016/j.amjcard.2011.03.003. Epub 2011 May 10.

PMID:
21565322
5.

Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol?

Sniderman A, McQueen M, Contois J, Williams K, Furberg CD.

J Clin Lipidol. 2010 May-Jun;4(3):152-5. doi: 10.1016/j.jacl.2010.03.005. Epub 2010 Mar 18. Review.

PMID:
21122647
6.

Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.

Berneis K, Jeanneret C, Muser J, Felix B, Miserez AR.

Metabolism. 2005 Feb;54(2):227-34.

PMID:
15690318
7.

Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.

Kastelein JJ, van der Steeg WA, Holme I, Gaffney M, Cater NB, Barter P, Deedwania P, Olsson AG, Boekholdt SM, Demicco DA, Szarek M, LaRosa JC, Pedersen TR, Grundy SM; TNT Study Group; IDEAL Study Group.

Circulation. 2008 Jun 10;117(23):3002-9. doi: 10.1161/CIRCULATIONAHA.107.713438. Epub 2008 Jun 2.

8.

Utility of non-high-density lipoprotein cholesterol versus other lipoprotein measures in detecting subclinical atherosclerosis in young adults (The Bogalusa Heart Study).

Frontini MG, Srinivasan SR, Xu JH, Tang R, Bond MG, Berenson G.

Am J Cardiol. 2007 Jul 1;100(1):64-8. Epub 2007 May 11.

PMID:
17599442
9.

Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.

Granata A, Sobbrio GA, D'Arrigo F, Barillari M, Curasì MP, Egitto M, Trimarchi F, Granese D, Pullè C.

Acta Eur Fertil. 1990 May-Jun;21(3):143-6.

PMID:
2149913
10.

Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.

Hummel J, Westphal S, Weber-Hamann B, Gilles M, Lederbogen F, Angermeier T, Luley C, Deuschle M, Kopf D.

J Clin Psychiatry. 2011 Jul;72(7):885-91. doi: 10.4088/JCP.09m05853blu. Epub 2011 Jan 25.

PMID:
21294998
11.

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB.

Circulation. 2005 Nov 29;112(22):3375-83.

12.

The association of apolipoprotein B and low density lipoprotein with cardiovascular risk factors in the Thai population.

Krittayaphong R, Chotinaiwatarakul C, Kangkagate C, Bhuripanyo K, Mahanonda N.

J Med Assoc Thai. 2006 Nov;89 Suppl 5:S1-7.

PMID:
17722296
15.

Measurement of plasma small-dense LDL concentration by a simplified ultracentrifugation procedure and immunoassay of apolipoprotein B.

Menys VC, Liu Y, Mackness MI, Caslake MJ, Kwok S, Durrington PN.

Clin Chim Acta. 2003 Aug;334(1-2):95-106.

PMID:
12867279
16.

Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels.

Ballantyne CM, Andrews TC, Hsia JA, Kramer JH, Shear C; ACCESS Study Group. Atorvastatin Comparative Cholesterol Efficacy and Safety Study.

Am J Cardiol. 2001 Aug 1;88(3):265-9.

PMID:
11472705
17.

Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patients(1).

Bairaktari E, Elisaf M, Tzallas C, Karabina SA, Tselepis AD, Siamopoulos KC, Tsolas O.

Clin Biochem. 2001 Nov;34(8):593-602.

PMID:
11849617
18.

The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy.

Eirís J, Novo-Rodríguez MI, Del Río M, Meseguer P, Del Río MC, Castro-Gago M.

Epilepsy Res. 2000 Aug;41(1):1-7.

PMID:
10924863
19.

Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.

Hunt SC, Wu LL, Hopkins PN, Stults BM, Kuida H, Ramirez ME, Lalouel JM, Williams RR.

Arteriosclerosis. 1989 May-Jun;9(3):335-44.

20.

Relationship between high-density lipoprotein-cholesterol and malondialdehyde-modified low-density lipoprotein concentrations.

Kondo A, Li J, Manabe M, Saito K, Kanno T, Maekawa M.

J Atheroscler Thromb. 2003;10(2):72-8.

Items per page

Supplemental Content

Write to the Help Desk